POC PCR-test device: The analysis will follow an intention-to-treat principle, that is, contacts in the intervention period will be analyzed as randomized, regardless of whether the POC PCR test was actually performed for a given contact. As sensitivity analysis, the data will be analyzed in a "per-protocol" spirit, defining the intervention at the contact level as a POC PCR test performed.
Study summary
The present study will assess the effect and cost-effectiveness of the availability of point-of-care (POC) PCR testing, in respiratory tract infections (RTIs) in general practice, compared with usual care.
Eligibility
Sex
ALL
Min age
0 Years
Max age
—
Healthy volunteers
Accepted
Inclusion criteria:
* GP clinics are eligible for participation when they have a clinic provider number ("ydernummer").
* Any patient with symptoms of RTI independent of age, gender, socioeconomic factors are eligible for POC PCR testing, if the GP finds it clinically relevant.
* Questionnaire data will be collected from patients ≥15 years old, parents/caregivers to patients ˂15 years and GPs.
* Qualitative data will be collected from consenting patients and/or parents/caregivers to patients \<15 years and healthcare staff
Exclusion criteria:
\- Questionnaire data of participants below 15 years
Primary outcome measure(s)
Reduction of respiratory tract infections (RTI) patients' re-contacts to General Practitioners — 2 x 7 weeks of trial = 14 weeks in total (exclusive crossover) The primary outcome measure is change in the number of re-contacts within a time period of 7 days from initial contact for each patient consulting with a clinic for a RTI in the intervention period compared to the control period. The re-contacts include any daytime contacts to general practice and are based on data from the national Danish registries. RTI patients may present themselves with symptoms often associated with RTI, e.g., fever, cough, sore throat etc., but it is up to the treating clinician to categorize patients as having a RTI.
Each time period (i.e., intervention and control) consists of 7 weeks.
Trial sites (1)
Facility
City
Region
Status
Research Unit of General Practice, Dept. of Public Health, University of Southern Denmark
Odense C
Denmark
More University of Southern Denmark trials in Denmark
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.